Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer.

Sinn BV, Fu C, Lau R, Litton J, Tsai TH, Murthy R, Tam A, Andreopoulou E, Gong Y, Murthy R, Gould R, Zhang Y, King TA, Viale A, Andrade V, Giri D, Salgado R, Laios I, Sotiriou C, Marginean EC, Kwiatkowski DN, Layman RM, Booser D, Hatzis C, Vicente Valero V, Fraser Symmans W.

NPJ Breast Cancer. 2019 May 30;5:16. doi: 10.1038/s41523-019-0111-0. eCollection 2019.

2.

Relevance of histology in the diagnosis of reflux esophagitis.

Tripathi M, Streutker CJ, Marginean EC.

Ann N Y Acad Sci. 2018 Dec;1434(1):94-101. doi: 10.1111/nyas.13742. Epub 2018 May 16. Review.

PMID:
29766511
3.

Gastrointestinal pathologists' perspective on managing risk in the distal esophagus: convergence on a pragmatic approach.

Bellizzi AM, Hafezi-Bakhtiari S, Westerhoff M, Marginean EC, Riddell RH.

Ann N Y Acad Sci. 2018 Dec;1434(1):35-45. doi: 10.1111/nyas.13680. Epub 2018 May 11. Review.

PMID:
29749623
4.
6.

NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine.

Alkayyal AA, Tai LH, Kennedy MA, de Souza CT, Zhang J, Lefebvre C, Sahi S, Ananth AA, Mahmoud AB, Makrigiannis AP, Cron GO, Macdonald B, Marginean EC, Stojdl DF, Bell JC, Auer RC.

Cancer Immunol Res. 2017 Mar;5(3):211-221. doi: 10.1158/2326-6066.CIR-16-0162. Epub 2017 Feb 3.

7.

The Ever-Changing Landscape of Drug-Induced Injury of the Lower Gastrointestinal Tract.

Marginean EC.

Arch Pathol Lab Med. 2016 Aug;140(8):748-58. doi: 10.5858/arpa.2015-0451-RA. Review.

PMID:
27472233
8.

Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial.

Horgan AM, Darling G, Wong R, Guindi M, Liu G, Jonker DJ, Lister J, Xu W, MacKay HM, Dinniwell R, Kim J, Pierre A, Shargall Y, Asmis TR, Agboola O, Seely AJ, Ringash J, Wells J, Marginean EC, Haider M, Knox JJ.

Dis Esophagus. 2016 Nov;29(8):1152-1158. doi: 10.1111/dote.12444. Epub 2015 Dec 10.

PMID:
26663741
9.

Clinical and pathological features of intraductal papillary neoplasm of the biliary tract and gallbladder.

Bennett S, Marginean EC, Paquin-Gobeil M, Wasserman J, Weaver J, Mimeault R, Balaa FK, Martel G.

HPB (Oxford). 2015 Sep;17(9):811-8. doi: 10.1111/hpb.12460.

10.

The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas.

Paliga A, Marginean H, Tessier-Cloutier B, Purgina B, Jonker D, Marginean EC.

Am J Clin Oncol. 2017 Dec;40(6):543-551. doi: 10.1097/COC.0000000000000202.

PMID:
26125303
11.

Evaluation of Quantitative Digital Pathology in the Assessment of Barrett Esophagus-Associated Dysplasia.

El Hallani S, Guillaud M, Korbelik J, Marginean EC.

Am J Clin Pathol. 2015 Jul;144(1):151-64. doi: 10.1309/AJCPK0Y1MMFSJDKU.

PMID:
26071473
12.

Radiologist's perspective for the Meckel's diverticulum and its complications.

Kotha VK, Khandelwal A, Saboo SS, Shanbhogue AK, Virmani V, Marginean EC, Menias CO.

Br J Radiol. 2014 May;87(1037):20130743. doi: 10.1259/bjr.20130743. Epub 2014 Feb 17. Review.

13.

Anaplastic large cell lymphoma of the colon in a patient with colonic Crohn disease treated with infliximab and methotrexate.

Shukla T, Jin J, Marginean EC, Saloojee N.

Can J Gastroenterol Hepatol. 2014 Jan;28(1):11-2. No abstract available.

14.

Diagnostic Approach to Hepatic Mass Lesions and Role of Immunohistochemistry.

Marginean EC, Gown AM, Jain D.

Surg Pathol Clin. 2013 Jun;6(2):333-65. doi: 10.1016/j.path.2013.03.005. Epub 2013 May 4.

PMID:
26838978
15.

Predicting OncoDx recurrence scores with immunohistochemical markers.

Bradshaw SH, Pidutti D, Gravel DH, Song X, Marginean EC, Robertson SJ.

Appl Immunohistochem Mol Morphol. 2013 Dec;21(6):490-6. doi: 10.1097/PAI.0b013e3182810b8e.

PMID:
23455176
16.

Isolated granulomatous hepatitis-A histopathological surprise mimicking cholangiocarcinoma in ulcerative colitis.

Khandelwal A, Gorsi U, Marginean EC, Papadatos D, George U.

Ann Hepatol. 2013 Mar-Apr;12(2):332-5.

17.

Immunostaining as a diagnostic aid in cytopathologic study of upper urinary tract urothelial carcinoma.

Mai KT, Teo I, Robertson SJ, Marginean EC, Islam S, Yazdi HM.

Acta Cytol. 2009 Nov-Dec;53(6):611-8.

PMID:
20014548
18.
19.

Oncocytic papillary renal cell carcinoma with solid architecture: mimic of renal oncocytoma.

Mai KT, Kohler DM, Robertson SJ, Belanger EC, Marginean EC.

Pathol Int. 2008 Mar;58(3):164-8. doi: 10.1111/j.1440-1827.2007.02205.x.

PMID:
18251779
20.

Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.

Mai KT, Teo I, Belanger EC, Robertson SJ, Marginean EC, Islam S.

Histopathology. 2008 Feb;52(3):277-82. Epub 2007 Dec 13.

PMID:
18081814
21.

Gastric siderosis: patterns and significance.

Marginean EC, Bennick M, Cyczk J, Robert ME, Jain D.

Am J Surg Pathol. 2006 Apr;30(4):514-20.

PMID:
16625099
22.

Diabetes mellitus as the presenting feature of extrahepatic cholangiocarcinoma in situ: case report and review of literature.

Costa DB, Chen AA, Marginean EC, Inzucchi SE.

Endocr Pract. 2004 Sep-Oct;10(5):417-23.

PMID:
15760789
23.

Alcoholic pancreatitis: is it a priori chronic disease?

Marginean EC, Jain D.

J Clin Gastroenterol. 2004 Mar;38(3):203-5. No abstract available.

PMID:
15128063

Supplemental Content

Loading ...
Support Center